rs229527
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Graves Disease
0.810
GeneticVariation
BEFREE
We found both the rs229527 allele within C1QTNF6 (odds ratio [OR] = 1.23, confidence interval [95% CI]: 1.12-1.33, p<sub>Allelic</sub> = 4.60 × 10<sup>-6</sup>) and the rs2284038 allele within RAC2 (OR = 1.10, 95% CI: 1.01-0.19, p<sub>Allelic</sub> = 3.00 × 10<sup>-2</sup>) showed significant associations with GD susceptibility.
28665696
2017
rs229541
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Diabetes Mellitus, Insulin-Dependent
0.810
GeneticVariation
BEFREE
The most significant association was with two T1D SNPs, rs12150079 (ZPBP2/ORMDL3/GSDMB region) (enterovirus frequency: AA 7.3%, AG 8.7%, GG 9.7%, RR = 0.86, overall p = 1.87E-02) and rs229541 (C1QTNF6/SSTR3/RAC2) (enterovirus frequency: CC 7.8%, CT 9.7%, TT 9.4%, RR = 1.13, overall p = 3.6E-02), followed by TLR8 (rs2407992) (p = 3.8E-02), TLR3 (1914926) (p = 4.9E-02), and two other T1D SNPs (IFIH1 rs3747517, p = 4.9E-02 and PTPN22, rs2476601, p = 5.3E-02).
26485223
2015
rs229527
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Graves Disease
0.810
GeneticVariation
GWASCAT
Robust evidence for five new Graves' disease risk loci from a staged genome-wide association analysis.
23612905
2013
rs229527
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Graves Disease
0.810
GeneticVariation
GWASDB
Robust evidence for five new Graves' disease risk loci from a staged genome-wide association analysis.
23612905
2013
rs229541
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Diabetes Mellitus, Insulin-Dependent
0.810
GeneticVariation
GWASCAT
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.
19430480
2009
rs229541
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Diabetes Mellitus, Insulin-Dependent
0.810
GeneticVariation
GWASDB
Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.
19430480
2009
rs229541
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Diabetes Mellitus, Insulin-Dependent
T
0.810
GeneticVariation
GWASCAT
Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci.
18978792
2008
rs229541
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Diabetes Mellitus, Insulin-Dependent
T
0.810
GeneticVariation
GWASDB
Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci.
18978792
2008
rs229527
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Vitiligo
A
0.800
GeneticVariation
GWASCAT
Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants.
27723757
2016
rs229527
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Vitiligo
0.800
GeneticVariation
GWASDB
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.
22561518
2012
rs229527
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Vitiligo
0.800
GeneticVariation
GWASDB
Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset.
21326295
2011
rs229527
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Vitiligo
T
0.800
GeneticVariation
GWASDB
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.
20410501
2010
rs229527
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Vitiligo
T
0.800
GeneticVariation
GWASCAT
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo.
20410501
2010
rs229540
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Hypothyroidism
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs229541
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs229541
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs229541
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs229541
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Autoimmune Diseases
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs229541
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Lupus Erythematosus, Systemic
T
0.700
GeneticVariation
GWASCAT
Transancestral mapping and genetic load in systemic lupus erythematosus.
28714469
2017
rs229533
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Diabetes Mellitus, Insulin-Dependent
C
0.700
GeneticVariation
GWASCAT
Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers.
25751624
2015
rs229526
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Diabetes Mellitus, Insulin-Dependent
0.700
GeneticVariation
GWASDB
A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci.
21980299
2011
rs229541
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Multiple Sclerosis
0.700
GeneticVariation
GWASDB
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
22190364
2011
rs229541
×
Entrez Id:
114904
Gene Symbol:
C1QTNF6
C1QTNF6
Enterovirus Infections
0.010
GeneticVariation
BEFREE
The most significant association was with two T1D SNPs, rs12150079 (ZPBP2/ORMDL3/GSDMB region) (enterovirus frequency: AA 7.3%, AG 8.7%, GG 9.7%, RR = 0.86, overall p = 1.87E-02) and rs229541 (C1QTNF6/SSTR3/RAC2) (enterovirus frequency: CC 7.8%, CT 9.7%, TT 9.4%, RR = 1.13, overall p = 3.6E-02), followed by TLR8 (rs2407992) (p = 3.8E-02), TLR3 (1914926) (p = 4.9E-02), and two other T1D SNPs (IFIH1 rs3747517, p = 4.9E-02 and PTPN22, rs2476601, p = 5.3E-02).
26485223
2015